Skip to main content
Top
Published in: BMC Geriatrics 1/2019

Open Access 01-12-2019 | Arthritis | Research article

The burden of health conditions for middle-aged and older adults in the United States: disability-adjusted life years

Authors: Ryan McGrath, Soham Al Snih, Kyriakos Markides, Orman Hall, Mark Peterson

Published in: BMC Geriatrics | Issue 1/2019

Login to get access

Abstract

Background

Many adults are living longer with health conditions in the United States. Understanding the disability-adjusted life years (DALYs) for such health conditions may help to inform healthcare providers and their patients, guide health interventions, reduce healthcare costs, improve quality of life, and increase longevity for aging Americans. The purpose of this study was to determine the burden of 10 health conditions for a nationally-representative sample of adults aged 50 years and older in the United States.

Methods

Data from the 1998–2014 waves of the Health and Retirement Study were analyzed. At each wave, participants indicated if they were diagnosed with the following 10 conditions: cancer, chronic obstructive pulmonary disease (COPD), congestive heart failure, diabetes, back pain, hypertension, a fractured hip, myocardial infarction, rheumatism or arthritis, and a stroke. Years lived with a disability and years of life lost to premature mortality were summed for calculating DALYs. Sample weights were utilized in the analyses to make the DALY estimates nationally-representative. Results for the DALYs were presented in thousands.

Results

There were 30,101 participants included. Sex stratified DALY estimates ranged from 4092 (fractured hip)-to-178,055 (hypertension) for men and 13,621 (fractured hip)-to-200,794 (hypertension) for women. The weighted overall DALYs were: 17,660 for hip fractures, 62,630 for congestive heart failure, 64,710 for myocardial infarction, 90,337 for COPD, 93,996 for stroke, 142,012 for cancer, 117,534 for diabetes, 186,586 for back pain, 333,420 for arthritis, and 378,849 for hypertension. In total, there were an estimated 1,487,734 years of healthy life lost from the 10 health conditions examined over the study period.

Conclusions

The burden of these health conditions accounted for over a million years of healthy life lost for middle-aged and older Americans over the 16 year study period. Our results should be used to inform healthcare providers and guide health interventions aiming to improve the health of middle-aged and older adults. Moreover, shifting health policy and resources to match DALY trends may help to improve quality of life during aging and longevity.
Appendix
Available only for authorised users
Literature
1.
go back to reference Niccoli T, Partridge L. Ageing as a risk factor for disease. Curr Biol. 2012;22:R741–52.CrossRef Niccoli T, Partridge L. Ageing as a risk factor for disease. Curr Biol. 2012;22:R741–52.CrossRef
2.
go back to reference Ward BW, Schiller JS, Goodman RA. Multiple chronic conditions among US adults: a 2012 update. Prev Chronic Dis. 2014;11:E62.PubMedPubMedCentral Ward BW, Schiller JS, Goodman RA. Multiple chronic conditions among US adults: a 2012 update. Prev Chronic Dis. 2014;11:E62.PubMedPubMedCentral
4.
go back to reference Colby SL, Ortman JM. Projections of the size and composition of the US population: 2014 to 2060. Curr Popul Rep. 2015:P25–1143. Colby SL, Ortman JM. Projections of the size and composition of the US population: 2014 to 2060. Curr Popul Rep. 2015:P25–1143.
6.
go back to reference Grosse SD, Lollar DJ, Campbell VA, Chamie M. Disability and disability-adjusted life years: not the same. Public Health Rep. 2009;124:197–202.CrossRef Grosse SD, Lollar DJ, Campbell VA, Chamie M. Disability and disability-adjusted life years: not the same. Public Health Rep. 2009;124:197–202.CrossRef
8.
go back to reference Fox-Rushby J. Disability-adjusted life years (DALYs) for decision-making?: an overview of the literature. London: BSC Print Ltd; 2002. Office of Health Economics Fox-Rushby J. Disability-adjusted life years (DALYs) for decision-making?: an overview of the literature. London: BSC Print Ltd; 2002. Office of Health Economics
10.
go back to reference Sonnega A, Faul JD, Ofstedal MB, Langa KM, Phillips JW, Weir DR. Cohort profile: the health and retirement study (HRS). Int J Epidemiol. 2014;43:576–85.CrossRef Sonnega A, Faul JD, Ofstedal MB, Langa KM, Phillips JW, Weir DR. Cohort profile: the health and retirement study (HRS). Int J Epidemiol. 2014;43:576–85.CrossRef
12.
go back to reference Salomon JA, Haagsma JA, Davis A, de Noordhout CM, Polinder S, Havelaar AH, Cassini A, Devleesschauwer B, Kretzschmar M, Speybroeck N. Disability weights for the global burden of disease 2013 study. Lancet Glob Health. 2015;3:e712–23.CrossRef Salomon JA, Haagsma JA, Davis A, de Noordhout CM, Polinder S, Havelaar AH, Cassini A, Devleesschauwer B, Kretzschmar M, Speybroeck N. Disability weights for the global burden of disease 2013 study. Lancet Glob Health. 2015;3:e712–23.CrossRef
15.
go back to reference Struijk EA, May AM, Beulens JW, de Wit GA, Boer JM, Onland-Moret NC, van der Schouw YT, Bueno-de-Mesquita HB, Hoekstra J, Peeters PH. Development of methodology for disability-adjusted life years (DALYs) calculation based on real-life data. PLoS One. 2013;8:e74294.CrossRef Struijk EA, May AM, Beulens JW, de Wit GA, Boer JM, Onland-Moret NC, van der Schouw YT, Bueno-de-Mesquita HB, Hoekstra J, Peeters PH. Development of methodology for disability-adjusted life years (DALYs) calculation based on real-life data. PLoS One. 2013;8:e74294.CrossRef
17.
go back to reference Lim SS, Vos T, Flaxman AD, Danaei G, Shibuya K, Adair-Rohani H, AlMazroa MA, Amann M, Anderson HR, Andrews KG. A comparative risk assessment of burden of disease and injury attributable to 67 risk factors and risk factor clusters in 21 regions, 1990–2010: a systematic analysis for the global burden of disease study 2010. Lancet. 2012;380:2224–60.CrossRef Lim SS, Vos T, Flaxman AD, Danaei G, Shibuya K, Adair-Rohani H, AlMazroa MA, Amann M, Anderson HR, Andrews KG. A comparative risk assessment of burden of disease and injury attributable to 67 risk factors and risk factor clusters in 21 regions, 1990–2010: a systematic analysis for the global burden of disease study 2010. Lancet. 2012;380:2224–60.CrossRef
18.
go back to reference Lionakis N, Mendrinos D, Sanidas E, Favatas G, Georgopoulou M. Hypertension in the elderly. World J Cardiol. 2012;4:135–47.CrossRef Lionakis N, Mendrinos D, Sanidas E, Favatas G, Georgopoulou M. Hypertension in the elderly. World J Cardiol. 2012;4:135–47.CrossRef
19.
go back to reference Thomopoulos C, Parati G, Zanchetti AJ. Effects of blood pressure-lowering treatment on cardiovascular outcomes and mortality: 14–effects of different classes of antihypertensive drugs in older and younger patients overview and meta-analysis. J Hypertens. 2018;36:1637–47.CrossRef Thomopoulos C, Parati G, Zanchetti AJ. Effects of blood pressure-lowering treatment on cardiovascular outcomes and mortality: 14–effects of different classes of antihypertensive drugs in older and younger patients overview and meta-analysis. J Hypertens. 2018;36:1637–47.CrossRef
20.
go back to reference Kim S, Shin DW, Yun JM, Hwang Y, Park SK, Ko Y-J, Cho B. Medication adherence and the risk of cardiovascular mortality and hospitalization among patients with newly prescribed antihypertensive medications. Hypertension. 2016;67:506–12.CrossRef Kim S, Shin DW, Yun JM, Hwang Y, Park SK, Ko Y-J, Cho B. Medication adherence and the risk of cardiovascular mortality and hospitalization among patients with newly prescribed antihypertensive medications. Hypertension. 2016;67:506–12.CrossRef
21.
go back to reference Frieden TR, Jaffe MG. Saving 100 million lives by improving global treatment of hypertension and reducing cardiovascular disease risk factors. J Clin Hypertens. 2018;20:208–11.CrossRef Frieden TR, Jaffe MG. Saving 100 million lives by improving global treatment of hypertension and reducing cardiovascular disease risk factors. J Clin Hypertens. 2018;20:208–11.CrossRef
22.
go back to reference Cross M, Smith E, Hoy D, Carmona L, Wolfe F, Vos T, Williams B, Gabriel S, Lassere M, Johns N. The global burden of rheumatoid arthritis: estimates from the global burden of disease 2010 study. Ann Rheum Dis. 2014;73:1316–22.CrossRef Cross M, Smith E, Hoy D, Carmona L, Wolfe F, Vos T, Williams B, Gabriel S, Lassere M, Johns N. The global burden of rheumatoid arthritis: estimates from the global burden of disease 2010 study. Ann Rheum Dis. 2014;73:1316–22.CrossRef
23.
go back to reference Wong AY, Karppinen J, Samartzis D. Low back pain in older adults: risk factors, management options and future directions. Scoliosis Spinal Disord. 2017;12:14.CrossRef Wong AY, Karppinen J, Samartzis D. Low back pain in older adults: risk factors, management options and future directions. Scoliosis Spinal Disord. 2017;12:14.CrossRef
24.
go back to reference Murray CJ, Abraham J, Ali MK, Alvarado M, Atkinson C, Baddour LM, Bartels DH, Benjamin EJ, Bhalla K, Birbeck G. The state of US health, 1990-2010: burden of diseases, injuries, and risk factors. JAMA. 2013;310:591–606.CrossRef Murray CJ, Abraham J, Ali MK, Alvarado M, Atkinson C, Baddour LM, Bartels DH, Benjamin EJ, Bhalla K, Birbeck G. The state of US health, 1990-2010: burden of diseases, injuries, and risk factors. JAMA. 2013;310:591–606.CrossRef
25.
go back to reference GBD 2016 Disease and Injury Incidence and Prevalence Collaborators. Global, regional, and national incidence, prevalence, and years lived with disability for 328 diseases and injuries for 195 countries, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet. 2017;390:1211–59.CrossRef GBD 2016 Disease and Injury Incidence and Prevalence Collaborators. Global, regional, and national incidence, prevalence, and years lived with disability for 328 diseases and injuries for 195 countries, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet. 2017;390:1211–59.CrossRef
26.
go back to reference Cinar D, Tas D. Cancer in the elderly. N Clin Istanb. 2015;2:73–80. Cinar D, Tas D. Cancer in the elderly. N Clin Istanb. 2015;2:73–80.
27.
go back to reference Berger NA, Savvides P, Koroukian SM, Kahana EF, Deimling GT, Rose JH, Bowman KF, Miller RH. Cancer in the elderly. Trans Am Clin Climatol Assoc. 2006;117:147–55.PubMedPubMedCentral Berger NA, Savvides P, Koroukian SM, Kahana EF, Deimling GT, Rose JH, Bowman KF, Miller RH. Cancer in the elderly. Trans Am Clin Climatol Assoc. 2006;117:147–55.PubMedPubMedCentral
28.
go back to reference Kirkman MS, Briscoe VJ, Clark N, Florez H, Haas LB, Halter JB, Huang ES, Korytkowski MT, Munshi MN, Odegard PS. Diabetes in older adults. Diabetes Care. 2012;35:2650–64.CrossRef Kirkman MS, Briscoe VJ, Clark N, Florez H, Haas LB, Halter JB, Huang ES, Korytkowski MT, Munshi MN, Odegard PS. Diabetes in older adults. Diabetes Care. 2012;35:2650–64.CrossRef
29.
go back to reference Mokdad AH, Ballestros K, Echko M, Glenn S, Olsen HE, Mullany E, Lee A, Khan AR, Ahmadi A, Ferrari AJ. The state of US health, 1990-2016: burden of diseases, injuries, and risk factors among US states. JAMA. 2018;319:1444–72.CrossRef Mokdad AH, Ballestros K, Echko M, Glenn S, Olsen HE, Mullany E, Lee A, Khan AR, Ahmadi A, Ferrari AJ. The state of US health, 1990-2016: burden of diseases, injuries, and risk factors among US states. JAMA. 2018;319:1444–72.CrossRef
30.
go back to reference Kautzky-Willer A, Harreiter J, Pacini G. Sex and gender differences in risk, pathophysiology and complications of type 2 diabetes mellitus. Endocr Rev. 2016;37:278–316.CrossRef Kautzky-Willer A, Harreiter J, Pacini G. Sex and gender differences in risk, pathophysiology and complications of type 2 diabetes mellitus. Endocr Rev. 2016;37:278–316.CrossRef
31.
go back to reference Mozaffarian D, Benjamin EJ, Go AS, Arnett DK, Blaha MJ, Cushman M, De Ferranti S, Després J-P, Fullerton HJ, Howard VJ. Heart disease and stroke statistics—2015 update: a report from the American Heart Association. Circulation. 2015;131:e29–e322.PubMed Mozaffarian D, Benjamin EJ, Go AS, Arnett DK, Blaha MJ, Cushman M, De Ferranti S, Després J-P, Fullerton HJ, Howard VJ. Heart disease and stroke statistics—2015 update: a report from the American Heart Association. Circulation. 2015;131:e29–e322.PubMed
32.
go back to reference Di Carlo A. Human and economic burden of stroke. Age Ageing. 2009;38:4–5.CrossRef Di Carlo A. Human and economic burden of stroke. Age Ageing. 2009;38:4–5.CrossRef
33.
go back to reference Benjamin EJ, Blaha MJ, Chiuve SE, Cushman M, Das SR, Deo R, Floyd J, Fornage M, Gillespie C, Isasi C. Heart disease and stroke statistics-2017 update: a report from the American Heart Association. Circulation. 2017;135:e146–603.CrossRef Benjamin EJ, Blaha MJ, Chiuve SE, Cushman M, Das SR, Deo R, Floyd J, Fornage M, Gillespie C, Isasi C. Heart disease and stroke statistics-2017 update: a report from the American Heart Association. Circulation. 2017;135:e146–603.CrossRef
35.
go back to reference Quaderi SA, Hurst JR. The unmet global burden of COPD. Glob Health Epidemiol Genom. 2018;3:e4. Quaderi SA, Hurst JR. The unmet global burden of COPD. Glob Health Epidemiol Genom. 2018;3:e4.
36.
go back to reference May SM, Li JT. Burden of chronic obstructive pulmonary disease: healthcare costs and beyond. Allergy Asthma Proc. 2015;36:4–10.CrossRef May SM, Li JT. Burden of chronic obstructive pulmonary disease: healthcare costs and beyond. Allergy Asthma Proc. 2015;36:4–10.CrossRef
37.
go back to reference Mathers CD, Loncar D. Projections of global mortality and burden of disease from 2002 to 2030. PLoS Med. 2006;3:e442.CrossRef Mathers CD, Loncar D. Projections of global mortality and burden of disease from 2002 to 2030. PLoS Med. 2006;3:e442.CrossRef
39.
go back to reference Bundkirchen A, Schwinger RH. Epidemiology and economic burden of chronic heart failure. Eur Heart J Suppl. 2004;6:D57–60.CrossRef Bundkirchen A, Schwinger RH. Epidemiology and economic burden of chronic heart failure. Eur Heart J Suppl. 2004;6:D57–60.CrossRef
40.
go back to reference Salem K, ElKhateeb O. Gender-adjusted and age-adjusted economic inpatient burden of congestive heart failure: cost and disability-adjusted life-year analysis. ESC Heart Fail. 2017;4:259–65.CrossRef Salem K, ElKhateeb O. Gender-adjusted and age-adjusted economic inpatient burden of congestive heart failure: cost and disability-adjusted life-year analysis. ESC Heart Fail. 2017;4:259–65.CrossRef
41.
go back to reference Brauer CA, Coca-Perraillon M, Cutler DM, Rosen AB. Incidence and mortality of hip fractures in the United States. JAMA. 2009;302:1573–9.CrossRef Brauer CA, Coca-Perraillon M, Cutler DM, Rosen AB. Incidence and mortality of hip fractures in the United States. JAMA. 2009;302:1573–9.CrossRef
42.
go back to reference Stevens JA, Anne RR. Declining hip fracture rates in the United States. Age Ageing. 2010;39:500–3.CrossRef Stevens JA, Anne RR. Declining hip fracture rates in the United States. Age Ageing. 2010;39:500–3.CrossRef
43.
go back to reference Dyer SM, Crotty M, Fairhall N, Magaziner J, Beaupre LA, Cameron ID, Sherrington C. A critical review of the long-term disability outcomes following hip fracture. BMC Geriatr. 2016;16:158.CrossRef Dyer SM, Crotty M, Fairhall N, Magaziner J, Beaupre LA, Cameron ID, Sherrington C. A critical review of the long-term disability outcomes following hip fracture. BMC Geriatr. 2016;16:158.CrossRef
Metadata
Title
The burden of health conditions for middle-aged and older adults in the United States: disability-adjusted life years
Authors
Ryan McGrath
Soham Al Snih
Kyriakos Markides
Orman Hall
Mark Peterson
Publication date
01-12-2019
Publisher
BioMed Central
Published in
BMC Geriatrics / Issue 1/2019
Electronic ISSN: 1471-2318
DOI
https://doi.org/10.1186/s12877-019-1110-6

Other articles of this Issue 1/2019

BMC Geriatrics 1/2019 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.